GPT and metabolic dysfunction-associated steatotic liver disease: Risk of ALT elevation declined with advancing age, which is consistent with other reports that ALT levels correlate negatively with age [37]; epidemiologic studies of non-alcoholic fatty liver disease have consistently shown an inverse association between age and steatosis [38–40].